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Abstract
Background: Mounting evidence indicates that children who experience abuse and neglect are prone to chronic
diseases and premature mortality later in life. One mechanistic hypothesis for this phenomenon is that early life
adversity alters the expression or functioning of the glucocorticoid receptor (GR) throughout the course of life and
thereby increases sensitivity to inflammatory stimulation. An exaggerated pro-inflammatory response is generally
considered to be a key cause of postoperative cognitive dysfunction (POCD). The aim of this study was to examine
the effects of early life adversity on cognitive function and neuroinflammation after sevoflurane anesthesia in adult
rats and to determine whether such effects are associated with the epigenetic regulation of GR.
Methods: Wistar rat pups were repeatedly subjected to infant maternal separation (early life stress) from postnatal
days 2–21. In adulthood, their behavior and the signaling of hippocampal pro-inflammatory factors and nuclear
factor-kappa B (NF-κB) after sevoflurane anesthesia were evaluated. We also examined the effects of maternal
separation (MS) on the expression of GR and the DNA methylation status of the promoter region of exon 17 of GR
and whether behavioral changes and neuroinflammation after anesthesia were reversible when the expression of
GR was increased by altering DNA methylation.
Results: MS induced cognitive decline after sevoflurane inhalation in the Morris water maze and context fear
conditioning tests and enhanced the release of cytokines and the activation of astrocyte intracellular NF-κB
signaling induced by sevoflurane in the hippocampus of adult rats. Blocking NF-κB signaling by pyrrolidine
dithiocarbamate (PDTC) inhibited the release of cytokines. MS also reduced the expression of GR and upregulated
the methylation levels of the promoter region of GR exon 17, and such effects were reversed by treatment with the
histone deacetylase inhibitor trichostatin A (TSA) in adult rats. Moreover, TSA treatment in adult MS rats inhibited
the overactivation of astrocyte intracellular NF-κB signaling and the release of cytokines and alleviated cognitive
dysfunction after sevoflurane anesthesia.
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Conclusions: Early life stress induces cognitive dysfunction after sevoflurane anesthesia, perhaps due to the
aberrant methylation of the GR gene promoter, which reduces the expression of the GR gene and facilitates
exaggerated inflammatory responses.
Keywords: Sevoflurane, Neuroinflammation, Pro-inflammatory factors, Cognitive dysfunction, Glucocorticoid
receptor, DNA methylation
Background
Postoperative cognitive dysfunction (POCD) is a rela-
tively common and well-known complication in surgical
patients. The occurrence of POCD is associated with
increased mortality, risk of withdrawal from the labor
market, and dependency on social transfer payments [1, 2].
However, despite enormous research efforts in recent
decades, the pathogenesis of POCD remains obscure.
Mounting evidence has revealed that inflammation
plays a key role in the disease process [3–5]. Peripheral
inflammation due to surgical trauma and the release of
accompanying systemic inflammatory mediators have
been shown to influence inflammatory processes of the
central nervous system, triggering the activation of neu-
rogliocytes and the concurrent endogenous production
of pro-inflammatory cytokines [6–9]. Volatile anes-
thetics, particularly isoflurane and sevoflurane, directly
increased the production of pro-inflammatory cytokines
in the brains of mice and impaired the acquisition of
spatial memory in aged rats [10–12]. In addition to sur-
gical trauma and anesthetics, advanced age is one of
the main risk factors for the development of POCD
[13]. Aging has been associated with an exacerbated
inflammatory response in the normal aged brain when
the immune system is irritated [14, 15], which may in-
crease susceptibility to POCD in the aged [16–18].
However, the occurrence of POCD exhibits pronounced
individual differences in the elderly, and POCD is also
observed in younger and adult patients [2].
Accumulating evidence indicates that early life adver-
sity is associated with an increased risk for various long-
term mental and physical diseases, including depression,
anxiety, autoimmune disorders, diabetes, hypertension,
cardiovascular diseases, cancers, and premature mortal-
ity [19–25]. The consequences of early life adversity can
last a lifetime, even when individuals’ life situations
improve after experiencing early negative life events
[26, 27]. A hypothesis concerning the mechanism of
susceptibility to chronic diseases is that early life adversity
induces glucocorticoid insensitivity and exaggerates in-
flammatory responses to injury or infection [28]. Several
studies have shown that early life adversity results in an
increased methylation of the glucocorticoid receptor (GR)
gene promoter and reduced GR expression in rodents and
humans [29–31], which may lead to glucocorticoid
feedback resistance and GR desensitization [28, 32]. It is
generally accepted that GR signaling regulates the inflam-
matory response to noxious stimuli, and evidence has sup-
ported this hypothesis. Adult individuals who experienced
early life adversity were shown to have elevated levels of
C-reactive protein (CRP) and pro-inflammatory cytokines
(interleukin (IL)-1, IL-6, and tumor necrosis factor (TNF)-
α) compared with participants without early life stress
[33–36]. Furthermore, an animal study showed that early
life stress enhanced the production of pro-inflammatory
cytokines in response to viral infection [37]. Thus, will
early life adversity amplify the neuroinflammation in-
duced by volatile anesthetics or surgeries and increase
the risk of POCD?
The aim of this study was to examine whether early
life adversity induces cognitive decline and exaggerates
neuroinflammation after sevoflurane anesthesia in adult
rats. Moreover, we examined the effects of early life ad-
versity on the expression of GR and the methylation of
GR gene promoters and whether behavioral changes and
neuroinflammation after anesthesia were reversible if GR
expression was increased by altering DNA methylation.
Methods
Maternal separation model
All experimental procedures involving animals were
approved by the Animal Care and Use Committee of
Xuzhou Medical University (Xuzhou, Jiangsu Province,
China). Wistar rats were obtained from the Experimen-
tal Animal Center of the Xuzhou Medical University.
Male and female rats were housed together in standard
rat cages, each containing one male and two females.
Each female rat was housed separately after pregnancy.
Animals were maintained under standard laboratory
conditions, with a 12-h light/dark cycle (lights on at 6:00
a.m.), a room temperature of 23 ± 1 °C, and food and
water provided ad libitum. The pups remained undis-
turbed at birth (postnatal day 0, P0). Half of the male
pups from each litter were randomly assigned to
undergo maternal separation (MS). The other half of the
male pups and all female pups were kept with their dam
the entire time. The separated pups were removed from
the home cage and placed in a warm standard laboratory
cage for 6 h per day (7:00–10:00 and 13:00–16:00) from
P1 to P21 [38]. The pups were returned to the home
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cage and remained with their dam the rest of the time.
Following weaning, all pups were group-housed at P22
(6–7 per cage) according to gender and whether they
had been subjected to MS or not. We did not observe
any differences in body weight between MS rats and
normal rats (data not shown). Subsequent experiments
were performed when the animals reached adult age
(85–90 days old).
Rats anesthesia and treatment
Rats received 3% sevoflurane mixed with pure oxygen
for 2 h in anesthetizing chambers. Control groups re-
ceived pure oxygen for 2 h in identical chambers. The
anesthesia with 3% sevoflurane mixed with pure oxygen
for 2 h was clinically relevant and did not cause signifi-
cant changes in blood pressure and blood gas compared
with the control group (data not shown). Anesthetizing
chambers were placed on a heating pad, and the rat’s
body temperature was maintained at 37 ± 0.5 °C. The
concentrations of sevoflurane and oxygen were mea-
sured continuously (Drager, Lubeck, Schleswig-Holstein,
Germany). Anesthesia was terminated by discontinuing
sevoflurane and by administering pure oxygen until the
animal regained its righting reflex. To evaluate the role
of the nuclear factor-kappa B (NF-κB) signaling pathway,
pyrrolidine dithiocarbamate (PDTC; 100 mg/kg) [39], an
NF-κB inhibitor, was given to rats intraperitoneally
30 min before exposure to sevoflurane. For intervention
studies, the histone deacetylase inhibitor trichostatin A
(TSA) was used for the epigenetic regulation of the
glucocorticoid receptor. Rats were implanted with a
stainless steel guide cannula (22 gauge, RWD, China)
directed toward the left lateral ventricle (1.6 mm lateral
to the midline, 1.0 mm posterior to the bregma, and
4.0 mm below the surface of the dura). Other proce-
dures were performed as described in previous studies
[29]. A volume of 2 μl of TSA (100 ng/ml in DMSO)
was infused using a micro-syringe through the infu-
sion cannula for at least 1 min. Rats received a single
infusion daily for seven consecutive days before ex-
posure to sevoflurane.
Morris water maze tests
The Morris water maze (MWM) was a cylindrical,
black-painted pool (1.5 m in diameter, 0.6 m in height)
filled with water (0.3 m deep, 24 ± 1 °C) and divided into
four virtual quadrants, with one starting point in each
quadrant. A black-painted platform (10 cm diameter,
1 cm below water surface) was placed in the determinate
quadrant. The experimental room contained cues that
remained unchanged throughout the study. The move-
ments of the rats were recorded by a video-tracking/
computer-digitizing system (Shanghai Jiliang Software
Technology Co., Ltd., Shanghai, China). The P86 rats
were tested in the MWM four times per day for 4 days
(acquisition tests). Each rat was gently placed in the
water at one of the four starting points (in a random
order) along the water maze perimeter with its face
toward the wall of the pool. Rats were given 120 s to
find the platform and were then left on the platform for
30 s. If the rat did not find the hidden platform within
120 s, the researcher would gently guide it to the plat-
form, and its escape latency to find the platform was
then marked as 120 s. At the end of the MWM training
(P90), the platform was removed and the animals were
allowed to search in the pool for 120 s (probe test);
the number of crossings over the target area and the
search time in the target quadrant were recorded
[40]. Animals that performed MWM tests were not
used in other tests.
Context fear conditioning tests
Fear conditioning experiments were performed in an
acrylic conditioning chamber with a grid floor composed
of 19 stainless steel bars. A ventilation fan supplied back-
ground noise (65 db), and overhead infrared lights were
left on. An infrared camera was located on the walls to
monitor the rats’ freezing behavior. P86 rats were given
5 min to acclimate to the chamber and were then
presented with one tone (2.2 kHz and 96 dB for 30 s).
During the last 2 s of the tone, the rats were given a
single shock (2.0 mA, 2 s). After the shock, the rats
stayed in the chamber for 30 s and were then placed
back into their housing area. Memory retention was
assessed at 48 h post-conditioning. P88 rats were
returned to the original chamber and allowed to stay
there for 3 min. The chamber was maintained in the
same context as when the rats were conditioned but
without a footshock or tone. Freezing time during this
period was recorded as a measure of contextual fear
memory [41]. Animals that underwent context fear
conditioning tests were not used in other tests.
Hippocampus tissue preparation
Immediately after undergoing anesthesia with 10%
chloral hydrate (0.3 ml/100 g, i.p.), all animals were
sacrificed by decapitation. The hippocampus was rapidly
removed, frozen in liquid nitrogen, and then stored at
−80 °C until further processing. For enzyme-linked
immunosorbent assay and Western blot analysis, the
harvested hippocampus tissues were homogenized on
ice using radioimmunoprecipitation assay (RIPA) lysis
buffer supplemented with protease inhibitors (Beyotime
Institute of Biotechnology, Haimen, Jiangsu, China). The
lysates were collected and centrifuged at 12,000 rpm
for 15 min to extract total proteins. The EpiQuik™
Nuclear Extraction Kit (Epigentek, Brooklyn, NY,
USA) was used for the preparation of nucleoproteins
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from the hippocampal tissues according to the manu-
facturer’s instructions. The supernatant was quantified
for total protein using the bicinchoninic acid (BCA)
protein assay kit (Beyotime Institute of Biotechnology,
Haimen, Jiangsu, China).
Western blot analysis
Western blotting was used to determine the expression
of GR in the total protein extract and NF-κB p65 in the
nuclear extract from the hippocampal tissues. Equal
amounts of protein were loaded and separated by
sodium dodecyl sulfate-polyacrylamide gel electrop-
horesis (SDS-PAGE) and transferred to nitrocellulose
membranes (Millipore Corporation, Billerica, MA). The
membranes were blocked in 5% nonfat milk for 2 h at
room temperature and then incubated overnight at 4 °C
with rabbit anti-GR (1:200, Santa Cruz Biotechnology,
CA, USA), rabbit anti-NF-κB p65 (1:500, Abcam,
Cambridge, UK), and mouse anti-β-actin (1:1000, Sigma-
Aldrich). After the incubation, the membranes were
washed three times with phosphate-buffered saline (PBS,
pH 7.4) containing 0.3% Triton X-100 (PBS-T) and
incubated with corresponding secondary antibodies con-
jugated with horseradish peroxidase (1:500, ZSGB-BIO,
Beijing, China) for 2 h at room temperature. The protein
signals were finally visualized using an enhanced BCIP/
NBT Alkaline Phosphatase Color Development Kit
(Beyotime Biotechnology, Inc., Haimen, Jiangsu, China).
Enzyme-linked immunosorbent assay
TNF-α, IL-1β, and IL-6 levels were quantified using rat-
specific enzyme-linked immunosorbent assay (ELISA)
kits (Xitang Bio-tech. Co., Ltd, Shanghai, China) accord-
ing to the manufacturer’s instructions. The optical dens-
ity of each well was determined using a microplate
reader at 450 nm. Cytokine concentrations were calcu-
lated using standard curves generated using recombinant
TNF-α, IL-1β, and IL-6.
Immunofluorescent staining
Rats were anesthetized with 10% chloral hydrate (0.3 ml/
100 g, i.p.) and perfused transcardially with 200 ml of
0.9% saline followed by 300 ml of 4% paraformaldehyde
in 0.1 M phosphate buffer (pH 7.4). The brain tissues
were removed and postfixed in 4% paraformaldehyde
overnight and cryoprotected in 30% sucrose. Thirty-
micron-thick frozen sections from the rat brains were
cut using a freezing microtome and serially collected
throughout the hippocampus. Free-floating tissue sec-
tions were rinsed three times with PBS-T. The tissue
sections were incubated with 10% normal donkey serum
in PBS-T for 2 h, followed by incubation with rabbit
anti-p-NF-κB p65 (1:500, Cell Signaling Technology,
Inc., Beverly, MA) and mouse anti-glial fibrillary acidic
protein (GFAP) monoclonal antibody (1:600, Abcam,
Cambridge, UK) at 4 °C for 24 h. After three 5-min
rinses in PBS, the sections were incubated with donkey
anti-rabbit IgG conjugated to Alexa Fluor® 488 and don-
key anti-mouse IgG conjugated to Alexa Fluor® 594
(1:500, Life Technologies, Carlsbad, CA, USA) in the
dark for 2 h at 37 °C. Fluorescence intensity was visual-
ized under a confocal microscope (FV1000, Olympus
Corp., Tokyo, Japan). The intensity on four slides (three
to four sections per slide) was averaged for each animal
and then normalized by that of the control group.
Quantitative reverse transcriptase polymerase chain
reaction
Quantitative reverse transcriptase polymerase chain reac-
tion (qRT-PCR) was used to assess the mRNA levels of
GR in rat hippocampal tissue. Total RNA was extracted
using a TRIzol reagent kit (Invitrogen, USA) and tran-
scribed into cDNA using a high-capacity cDNA reverse
transcription kit (Applied Biosystems, Foster City, USA).
The PCR primers for GR were 5′-TAGGTGGGCGTC
AAGTGATT-3′ (forward) and 5′-GATCAGGAGCAA
AGCAGAGC-3′ (reverse). The primers for GAPDH
were 5′-CAAGGTCATCCATGACAACTTTG-3′ (for-
ward) and 5′-GTCCACCACCCTGTTGCTGTAG-3′
(reverse). Real-time PCR analysis was performed using
the Roche LightCycler® 480 detection system using a
SYBR® Select Master Mix Kit (Life Technologies,
Carlsbad, CA, USA). The relative expression levels of
GR were normalized to GAPDH.
DNA methylation assay
DNA was extracted from the hippocampal tissue using
the genome extraction kit (Generay Biotechnology,
Shanghai, China). Sodium bisulfite modification of DNA
was performed using the EpiTect Bisulfite kit (Qiagen,
Venlo, Netherlands) according to the manufacturer’s
protocol. PCR amplification was carried out in a 50-μl
reaction volume containing 25 μl of PCR master mix
(Qiagen, Germany), 2 μl of each primer, 2.5 μl of
bisulfite-modified DNA, and H2O. The thermocycler
protocol was as follows: a 4-min denaturation at 95 °C;
40 cycles of 30-s denaturation at 95 °C, a 30-s annealing
period at 55 °C, and a 40-s extension at 72 °C; and a
final 5-min extension at 72 °C. The PCR product
(285 bp) was used as a template for subsequent nested
PCR reactions. The PCR product (177 bp) was purified
and separated on a 2% agarose gel. The targeted DNA
fragment was extracted from the gel. Following elution
in Tris buffer, the PCR product was then subcloned into
the pTG19-T vector (Generay Biotechnology) according
to the manufacturer’s protocol. Ten plasmids containing
the exon 17 GR promoter DNA fragment were screened
and sequenced per animal.
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Statistical analysis
All of the data are presented as the mean ± SD of inde-
pendent experiments. For the escape latency data,
repeated-measures two-way ANOVAs between groups
were conducted. The post hoc Bonferroni test was used
to compare the differences in escape latency between
groups on each day of the MWM. One-way ANOVA
followed by the Student–Newman–Keuls post hoc test
or Student’s two-sample t test was performed for the
other behavioral tests, Western blotting, ELISA, and
methylation of all CpG sites within exon 17 of GR.
Statistical analysis was performed using SPSS 16.0 (SPSS,
Chicago IL) or GraphPad Prism 5.0 for Windows
(GraphPad Software, Inc., San Diego, CA). P values
<0.05 were considered to be statistically significant.
Results
Sevoflurane anesthesia induced cognitive impairment in
adult maternal separation rats
To elucidate the effect of MS on cognitive function after
sevoflurane inhalation in adult rats, we conducted
MWM tests and context fear conditioning (CFC) tests,
which are widely used to evaluate hippocampus-dependent
spatial reference learning and memory in rodents [42, 43].
A schematic illustration of the experimental timeline is
shown in Fig. 1a. The comparison of the time that each rat
Fig. 1 The effect of neonatal maternal separation on cognitive function after sevoflurane anesthesia in adult rats. a Schematic illustration of the
experimental timeline. MS maternal separation, Sev anesthesia with 3% sevoflurane for 2 h, MWM Morris water maze, CFC context fear conditioning.
b Anesthesia with 3% sevoflurane for 2 h in MS rats increased the escape latency in the acquisition phase of the MWM test on the third and fourth
days after sevoflurane anesthesia. There was no statistically significant interaction of time and group between groups. Analysis was performed with
repeated-measures two-way ANOVA. c The time in the target quadrant in the MS + sevoflurane group was less than those in the sevoflurane group
and MS group by the MWM probe test. d The number of crossings of the platform area was lower in the MS + sevoflurane group than in the other
three groups in the MWM probe test. e MS rats subjected to sevoflurane anesthesia exhibited reduced freezing to context when compared with
normal rats that received sevoflurane anesthesia and MS rats without anesthesia. *P < 0.05, **P < 0.01 versus control; +P < 0.05, ++P < 0.01
versus sevoflurane; #P < 0.05, ##P < 0.01 versus MS. Error bars represent the means ± SD (n = 10). Statistical analyses were performed using
a one-way ANOVA followed by Student–Newman–Keuls post hoc test
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took to reach the platform during reference training
(escape latency) showed that there was no statisti-
cally significant interaction of time and group be-
tween groups in the acquisition phase of the MWM
tests (F = 1.567, P = 0.145). The factors of days (F = 29.488,
P < 0.001) and groups (F = 4.714, P = 0.011) were statisti-
cally significant. The post hoc Bonferroni test showed that
the MS rats that received sevoflurane anesthesia had a
longer escape latency than the normal rats; the normal
rats that received sevoflurane anesthesia and the MS rats
without anesthesia on the third or fourth days after
sevoflurane anesthesia (Fig. 1b; post-anesthesia day 3,
P = 0.001 MS + sevoflurane versus control, P < 0.001
MS + sevoflurane versus sevoflurane, and P = 0.001 MS +
sevoflurane versus MS; post-anesthesia day 4, P = 0.014
MS + sevoflurane versus control, P = 0.013 MS + sevoflur-
ane versus sevoflurane, and P = 0.030 MS + sevoflurane
versus MS). Reference memory was assessed using the
MWM probe test on the fifth day. The time spent in the
target quadrant in the MS + sevoflurane group was
less than that in MS group and sevoflurane group
(Fig. 1c; P = 0.020 MS + sevoflurane versus sevoflurane
and P = 0.037 MS + sevoflurane versus MS). In addition,
the number of crossings of the platform area was lower in
the MS + sevoflurane group than in the other groups
(Fig. 1d; P = 0.001 MS + sevoflurane versus control,
P = 0.002 MS + sevoflurane versus sevoflurane, and
P = 0.007 MS + sevoflurane versus MS). MS rats
showed a significant cognitive decline after sevoflurane
anesthesia in MWM tests. The results of the CFC tests
were similar to those of the MWM tests; MS rats that
received sevoflurane anesthesia exhibited reduced immo-
bility (freezing) in the CFC test (Fig. 1e; P = 0.001 MS +
sevoflurane versus control, P < 0.001 MS + sevoflurane
versus sevoflurane, and P = 0.004 MS + sevoflurane versus
MS). No statistically significant differences were observed
among the control group, sevoflurane group, and MS
group in the MWM and CFC tests.
Maternal separation enhanced the release of cytokines
and activation of astrocytes and NF-κB signaling induced
by sevoflurane in the hippocampus
The above findings suggested that sevoflurane anesthesia
in MS rats might induce cognitive impairment; there-
fore, we continued to investigate the underlying mecha-
nisms. It has been reported that pro-inflammatory
cytokines, such as TNF-α, IL-1β, and IL-6, are associated
with cognitive impairment [6–9]. Therefore, we detected
the levels of TNF-α, IL-1β, and IL-6 in the hippocampi
of rats after sevoflurane anesthesia. An ELISA for TNF-
α showed that 3% sevoflurane anesthesia for 2 h
increases the levels of TNF-α at 0, 6, 12, and 24 h after
anesthesia both in control and MS rats, but the levels of
TNF-α in MS rats were markedly higher than in control
rats at each time point after anesthesia (Fig. 2a). The
changes in the levels of IL-1β and IL-6 in the hippocam-
pus were similar to those of TNF-α (Fig. 2b, c).
Previous studies have shown that inhaled anesthetic
can activate the NF-κB signaling pathway [44], which is
a core signaling pathway associated with the expression
of pro-inflammatory cytokines. To examine whether the
observed changes in inflammatory mediators are related
to the NF-κB signaling pathway, we determined the
expression of NF-κB p65 in the nuclear extracts from
the hippocampal tissues. Western blot analysis showed
that 3% sevoflurane anesthesia for 2 h increases the
levels of nuclear NF-κB p65 protein at 0, 6, 12, and 24 h
after anesthesia both in control and MS rats, but the
levels of nuclear NF-κB p65 in MS rats were markedly
higher than that in control rats at each time point after
anesthesia (Fig. 2d).
The glia is the main source of inflammatory cytokines in
the central nervous system. It has been reported that rats
with POCD had increased levels of pro-inflammatory
cytokines and astrocyte activation [9]. Activation of the
astroglial NF-κB signaling pathway can regulate neuroin-
flammation because it drives the transcription of several
pro-inflammatory molecules [45, 46]. We therefore
assessed the effects of sevoflurane anesthesia on astrocytes
and the astroglial NF-κB signaling pathway in the hippo-
campus between control and MS rats. GFAP immuno-
fluorescence was increased 12 h after anesthesia in both
the sevoflurane group and the MS + sevoflurane groups
(CA1, P = 0.040 sevoflurane versus control, P < 0.001 MS
+ sevoflurane versus MS; DG, P = 0.008 sevoflurane versus
control, P < 0.001 MS + sevoflurane versus MS). The fluor-
escence intensity of GFAP in MS + sevoflurane group rats
was markedly higher than that in sevoflurane group rats
(Fig. 3a, b; CA1, P < 0.001 MS + sevoflurane versus sevo-
flurane; DG, P = 0.003 MS + sevoflurane versus sevoflur-
ane). A similar change in the pattern was seen with
phosphorylated nuclear factor-kappa B (p-NF-κB p65)
(Fig. 3a, b). We also found that p-NF-κB p65 mainly co-
localized with GFAP in astrocytes (Fig. 3a, b) but not in
microglia in the hippocampus (data not shown), as re-
vealed by double immunofluorescence staining.
PDTC suppresses the enhancement effect of maternal
separation on NF-κB Activation and the release of pro-
inflammatory cytokines induced by sevoflurane in the
hippocampus
To determine whether the NF-κB signaling pathway was in-
volved in the increase of neuroinflammation after sevoflur-
ane anesthesia in MS rats, we evaluated the effect of the
NF-κB inhibitor PDTC on NF-κB activation and the release
of pro-inflammatory cytokines 12 h after anesthesia in MS
rats. Western blot analysis showed that PDTC pretreatment
significantly prevented the enhancement effect of MS on
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the levels of nuclear NF-κB p65 protein in MS rats
(Fig. 4a; t = 11.03, P < 0.001 PDTC versus saline). Ac-
cordingly, an ELISA showed that PDTC also markedly
suppressed the increase in hippocampal TNF-α, IL-1β,
and IL-6 levels (Fig. 4b–d; TNF-α, t = 11.05, P < 0.001
PDTC versus saline; IL-1β, t = 14.98, P < 0.001 PDTC
versus saline; IL-6, t = 14.57, P < 0.001 PDTC versus
saline). These data suggest that the abnormal activation of
the NF-κB signaling pathway induced by sevoflurane in
MS rats may play an important role in exaggerated
neuroinflammation.
Maternal separation alters the DNA methylation status of
exon 17 of the GR promoter region and decreases the
expression of GR
Why do MS rats exhibit unusually excessive activation
of NF-κB signaling and exaggerated neuroinflammation
after sevoflurane anesthesia? The interaction of GR-
mediated signaling with NF-κB signaling plays a key role
in the regulation of inflammatory responses. It has been
reported that early life adversity (such as less maternal
care and maltreatment) induces GR desensitization and
exaggerates inflammatory responses to injury or infection
[28]. We therefore tested the effects of MS on the expres-
sion of GR in adult rats. Western blot analysis showed
that MS decreased the expression levels of GR proteins in
the hippocampus (Fig. 5a; t = 4.508, P = 0.006 MS versus
control). MS-induced decreases of GR levels may be due
to decreases in the generation or increases in the degrad-
ation of GR. We therefore assessed the effects of MS on
the mRNA levels of GR. qRT-PCR analysis showed that
MS decreased the mRNA levels of GR in the hippocampi
of adult rats (Fig. 5b; t = 4.144, P = 0.002 MS versus con-
trol). To determine whether the DNA methylation of the
GR promoter alters the expression levels of GR, we tested
the methylation status of 17 CpG sites within the exon 17
GR promoter region from the hippocampal tissue in adult
rats. (Fig. 5c). Methylation analysis showed that MS rats
have a higher percentage of methylated clones than
control rats at most of the 17 CpG dinucleotides in the
exon 17 GR promoter region (Fig. 5d).
Trichostatin A reverses epigenetic alterations and
changes in GR expression mediated by MS
The above findings suggest that MS influences hip-
pocampal GR expression, possibly through epigenetic
Fig. 2 MS enhanced the release of cytokines and the expression of nuclear NF-κB p65 induced by sevoflurane in the hippocampus. a Sevoflurane
anesthesia for 2 h increased the levels of TNF-α at 0, 6, 12, and 24 h after anesthesia in both control and MS rats. The levels of TNF-α in MS rats
were higher than that in control rats at each time point after anesthesia. The changes in the levels of IL-1β (b), IL-6 (c), and nuclear NF-κB p65 (d)
in the hippocampus were similar to those of TNF-α. *P < 0.05, **P < 0.01 versus control; ##P < 0.01 versus MS; +P < 0.05, ++P < 0.01 MS + sevoflurane
versus sevoflurane (at the same time point). Error bars represent the means ± SD (n = 6). Statistical analyses were performed by one-way ANOVA
followed by Student–Newman–Keuls post hoc test
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alterations. We therefore investigated whether the im-
pact of MS is reversible by altering DNA methylation in
adults. Previous research has shown that the histone
deacetylase inhibitor TSA may induce the replication-
independent demethylation of ectopically methylated
genes by increasing histone acetylation. We therefore
tested the effects of TSA on the methylation status of
the exon 17 GR promoter and the expression of GR in
adult MS rats. Methylation analysis of the 17 CpG
dinucleotides of the exon 17 GR promoter showed that
TSA decreased the percentage of methylated clones rela-
tive to the vehicle treatment in adult MS rats (Fig. 6a).
qRT-PCR analysis showed that TSA increased the
mRNA levels of GR in the hippocampi of MS rats
(Fig. 6b; t = 5.230, P < 0.001 DMSO versus TSA).
Western blot analysis showed that TSA increased the
levels of GR proteins in the hippocampi of MS rats
(Fig. 6c; t = 3.592, P = 0.008 DMSO versus TSA).
Fig. 3 MS enhanced the activation of astrocytes and the astroglial NF-κB signaling pathway induced by 3% sevoflurane anesthesia for 2 h in the
hippocampus. a Sevoflurane anesthesia increased the fluorescence intensity of glial fibrillary acidic protein (GFAP) and phosphorylated nuclear
factor-kappa B (p-NF-κB p65) in the CA1 area of the hippocampus at 12 h after anesthesia in both the sevoflurane group and MS + sevoflurane
group, and the fluorescence intensity of GFAP and p-NF-κB p65 in the MS + sevoflurane group was obviously higher than that in the sevoflurane
group. Double immunofluorescence staining showed that p-NF-κB p65 (green) mainly co-localized (merged) with GFAP-positive reactive
astrocytes (red) in the CA1 area of the hippocampus. b The changes in the fluorescence intensity of GFAP and p-NF-κB p65 in the DG
area of the hippocampus were similar to those in the CA1 area of the hippocampus. *P < 0.05, **P < 0.01 versus control; ##P < 0.01 versus
MS; ++P < 0.01 MS + sevoflurane versus sevoflurane. Error bars represent the means ± SD (n = 6). Statistical analyses were performed by
one-way ANOVA followed by Student–Newman–Keuls post hoc test. CA1 cornu ammonis 1, DG dentate gyrus; bar = 100 μm
Zhu et al. Journal of Neuroinflammation  (2017) 14:6 Page 8 of 16
TSA reversed the effect of MS on the activation of NF-κB
signaling and neuroinflammatory responses to
sevoflurane
The effects of MS on the activation of NF-κB signaling
and neuroinflammatory responses to sevoflurane seem
to be partly associated with changes in the hippocampal
GR levels. Given that TSA treatment reversed the hippo-
campal expression of GR in adult MS rats, we tested the
activation of NF-κB signaling and neuroinflammatory
responses to sevoflurane in TSA—and vehicle-treated
MS rats. A volume of 2 μl of TSA (100 ng/ml in DMSO)
was infused into the lateral ventricle of MS rats for
seven consecutive days before exposure to sevoflurane.
Western blot analysis showed that TSA pretreatment
significantly prevented the enhancement effect of MS on
the levels of nuclear NF-κB p65 protein 12 h after
anesthesia in MS rats (Fig. 7a; t = 7.060, P < 0.001 DMSO
versus TSA). An ELISA showed that TSA pretreatment
also markedly suppressed the increase in hippocampal
TNF-α, IL-1β, and IL-6 levels 12 h after anesthesia in
adult MS rats (Fig. 7b–d; TNF-α, t = 8.564, P < 0.001
DMSO versus TSA; IL-1β, t = 6.954, P < 0.001 DMSO
versus TSA; IL-6, t = 3.169, P = 0.001 DMSO versus TSA).
The fluorescence intensity of GFAP in the TSA group rats
was markedly lower than that in the DMSO group rats at
12 h after anesthesia (Fig. 7e, f; CA1, t = 3.581, P = 0.005
DMSO versus TSA; DG, t = 4.188, P = 0.002 DMSO versus
TSA). A similar change in pattern was observed for
phosphorylated NF-κB (p-NF-κB p65) (Fig. 7e, f ).
TSA attenuated the sevoflurane-induced cognitive
impairment in adult maternal separation rats
Finally, we evaluated whether the reversal of the mater-
nal effect on GR expression and neuroinflammatory
responses to sevoflurane could attenuate sevoflurane-
induced cognitive impairment. TSA was infused into the
lateral ventricle of MS rats for seven consecutive days
(P78–P84) before exposure to sevoflurane. We con-
ducted the MWM (P86–P90) and CFC tests (P86–P88)
24 h after sevoflurane anesthesia. A schematic illustra-
tion of the experimental timeline is shown in Fig. 8a.
The comparison of the escape latency showed that there
was a statistically significant interaction between time
and group between the different groups in the acquisition
phase of the MWM test according to repeated-measures
two-way ANOVA (F = 5.926, P = 0.035). The factors of days
(F= 27.439, P < 0.001) and groups (F = 6.441, P = 0.029)
were statistically significant. The post hoc Bonferroni test
showed that the DMSO group rats had a longer escape
latency than the TSA group rats on the third and fourth
days after sevoflurane anesthesia (P88 and P89) (Fig. 8b;
post-anesthesia day 3, P = 0.003 DMSO versus TSA; post-
anesthesia day 4, P = 0.011 DMSO versus TSA). The time
in the target quadrant in the DMSO group rats was less
than that in the TSA group rats (Fig. 8c; t = 2.875, P = 0.021
DMSO versus TSA). There was no significant differ-
ence in the number of times across the platform area
between the two groups (Fig. 8d). The TSA group rats
showed increased immobility (freezing) at P88 (Fig. 8e;
t = 2.672, P = 0.032 DMSO versus TSA). The results of
the MWM and CFC tests revealed that TSA pretreat-
ment attenuated hippocampal-dependent memory im-
pairment induced by sevoflurane in MS rats.
Discussion
Sevoflurane is one of the most commonly used inhala-
tional anesthetics for general anesthesia. We first found
that sevoflurane anesthesia in adult (P85) MS rats in-
duced cognitive impairment. Moreover, we found that
anesthesia with 3% sevoflurane for 2 h induced cognitive
impairment only in MS rats and not in normal rats
(Fig. 1), which suggests that sevoflurane anesthesia-
induced cognitive impairment has different selectivity in
different individuals. These findings provide a possible
Fig. 4 PDTC inhibits the enhancement effect of maternal separation on NF-κB activation and the release of pro-inflammatory cytokines induced
by sevoflurane in MS rats. PDTC or vehicle (saline) was given to rats intraperitoneally 30 min before exposure to sevoflurane. a PDTC pretreatment
decreased the nuclear NF-κB p65 protein levels in the hippocampus 12 h after sevoflurane anesthesia. b PDTC pretreatment decreased TNF-α levels in
the hippocampus 12 h after sevoflurane anesthesia. c PDTC pretreatment decreased IL-1β levels in the hippocampus 12 h after sevoflurane anesthesia.
d PDTC pretreatment decreased IL-6 levels in the hippocampus 12 h after sevoflurane anesthesia. **P < 0.01 versus saline. Error bars represent the
means ± SD (n = 6). Statistical analyses were performed with Student’s two-sample t test
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explanation for the clinical observation that the occur-
rence of POCD shows distinct individual differences and
suggest that individuals who have experienced early life
adversity may have a predisposition to cognitive impair-
ment after anesthesia.
Accumulating evidence suggests a pivotal role for neu-
roinflammation in the POCD process. Pro-inflammatory
cytokine release and astrocyte activation were associated
with a decline in cognitive performance in humans and
animals [6–8]. Pro-inflammatory cytokines, such as TNF-
α, IL-1β, and IL-6, can be released by activated astro-
cytes, triggering neuroinflammation and leading to
cognitive dysfunction [9]. Higher concentrations of
pro-inflammatory cytokines inhibit long-term potenti-
ation and impair memory [47]. We found that 3%
sevoflurane anesthesia for 2 h increased the levels of
Fig. 5 Maternal separation attenuated the expression of GR and increased the percentage of methylated clones within the exon 17 glucocorticoid
receptor promoter region from the hippocampal tissues of adult rats. a GR protein levels in the hippocampal tissues of MS rats were lower compared
with those of control rats. b qRT-PCR (GAPDH as an internal control) showed that MS decreased the mRNA levels of GR in the hippocampus compared
with the control conditions. c The complete sequence map of exon 17 of the GR promoter region (bold), including the 17 CpG dinucleotides
(superscript numbers). d The frequency of methylation observed at each CpG site in the exon 17 GR promoter region showed that MS rats have
a higher percentage of methylated clones than control rats. *P < 0.05, **P < 0.01 versus control. Error bars represent the means ± SD (n = 6).
Statistical analyses were performed with Student’s two-sample t test
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TNF-α, IL-1β, and IL-6 in the hippocampus after anesthesia
in both normal and MS rats, but the degree of pro-
inflammatory cytokines increase in MS rats was markedly
higher than that in normal rats after anesthesia (Fig. 2).
These data suggest that sevoflurane anesthesia in adult MS
rats may cause cognitive impairment by inducing excessive
neuroinflammation. Sevoflurane anesthesia also increased
GFAP (the marker of astrocyte activation) immunofluores-
cence in the hippocampus after anesthesia in both normal
and MS rats. The degree of increase in GFAP immuno-
fluorescence in MS rats was higher than that in normal
rats, similar to the change in pro-inflammatory cytokine
levels (Fig. 3). These results further suggest that rats with
different early life experiences may have different neuroin-
flammatory reactions to sevoflurane anesthesia.
Inhalation anesthetics have been shown to activate
NF-κB signaling [39, 44]. NF-κB signaling plays a pivotal
role in immune and inflammatory responses. Inactive
NF-κB, a dimer of p50 and p65, remains in the cytosol.
In response to diverse internal and external inflamma-
tory stimuli, NF-κB p65 is phosphorylated and rapidly
translocates to the nucleus [48, 49]. In the current study,
we found that sevoflurane anesthesia activated hippo-
campal NF-κB signaling both in MS rats and normal
rats, but the levels of nuclear NF-κB p65 protein and the
fluorescence intensity of p-NF-κB p65 in the hippocam-
pus in MS rats were significantly higher than those in
normal rats (Figs. 2 and 3). These results suggest that
NF-κB signaling in MS rats was overactivated under
sevoflurane anesthesia. Next, we found that the pre-
inhibition of NF-κB signaling by PDTC significantly
suppressed excessive pro-inflammatory cytokine release
after sevoflurane anesthesia in MS rats (Fig. 4). These
results further suggest that the excessive activation of
NF-κB signaling was involved in the increase of neuroin-
flammation after sevoflurane anesthesia in MS rats.
Fig. 6 TSA decreased the percentage of methylated clones within the exon 17 GR promoter region and increased the expression of GR in the
hippocampal tissues in adult MS rats. A volume of 2 μl of TSA (100 ng/ml in DMSO) was infused into the lateral ventricle of MS rats for seven
consecutive days. a The frequency of methylation observed at each CpG site in the exon 17 GR promoter region showed that TSA decreased the
percentage of methylated clones relative to the DMSO treatment. b qRT-PCR (GAPDH as internal control) showed that TSA increased the mRNA
levels of GR in MS rats compared with the DMSO treatment. c TSA treatment increased the nuclear GR protein levels in the hippocampus of MS
rats relative to the DMSO treatment. *P < 0.05, **P < 0.01 versus DMSO. Error bars represent the means ± SD (n = 6). Statistical analyses were
performed with Student’s two-sample t test
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Given that glucocorticoid receptors (GRs) exert essen-
tial immunoregulatory and anti-inflammatory actions,
the interaction between GRs and NF-κB signaling is of
particular importance. In principle, GR signaling and
NF-κB signaling are mutually antagonistic. Dysregulated
GR signaling may enable exaggerated NF-κB signaling,
ultimately leading to greater inflammatory responses. In
the current study, a decreased expression of GR in MS
rats was observed, and MS rats had a greater percentage
of DNA methylation in the exon 17 GR promoter region
(Fig. 5). These findings are in agreement with those of
other studies that showed that early life adversity results
in greater methylation of the GR gene promoter and
reduced GR expression in rodents and humans, with
consequent increases in pro-inflammatory gene expres-
sion [29–34]. Therefore, we speculate that the MS
phenotype was associated with the downregulation of
GR and the increased production of pro-inflammatory
cytokines controlled by the pro-inflammatory transcrip-
tion factor NF-κB, which may worsen sevoflurane
anesthesia-induced neuroinflammation and ultimately
lead to cognitive impairment. A key question is whether
the impact of early experiences on epigenetic program-
ming is reversible in adults. It has been reported that
DNA methylation produced by insufficient maternal care
is reversible in the hippocampus of adult offspring
through the modulation of the chromatin structure
using the histone deacetylase inhibitor TSA [50]. His-
tone deacetylase prevents histone acetylation and en-
sures that histones bind tightly to DNA. The activation
of chromatin through histone deacetylase inhibition
might trigger DNA demethylation by increasing the
accessibility of methylated DNA to demethylase activity
[51]. We found that TSA decreased the percentage of
Fig. 7 TSA reversed the effects of MS on the activation of NF-κB signaling and neuroinflammatory responses to sevoflurane in the hippocampal
tissues in adult MS rats. a TSA pretreatment prevented the enhancement effect of MS on the levels of nuclear NF-κB p65 protein 12 h after
anesthesia. b–d TSA pretreatment suppressed the increase in hippocampal TNF-α, IL-1β, and IL-6 levels 12 h after anesthesia in adult MS rats.
e The fluorescence intensities of GFAP and p-NF-κB p65 in the TSA group rats were obviously lower than those in the DMSO group rats. Double
immunofluorescence staining showed that p-NF-κB p65 (green) mainly co-localized (merged) with GFAP-positive reactive astrocytes (red) in the
CA1 area of the hippocampus. f The changes in the fluorescence intensities of GFAP and p-NF-κB p65 in the DG area of the hippocampus were
similar to those in the CA1 area of the hippocampus. *P < 0.05, **P < 0.01 versus DMSO. Error bars represent the means ± SD (n = 6). Statistical
analyses were performed with Student’s two-sample t test
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DNA methylation in the exon 17 GR promoter region.
Then, marked increases in the hippocampal GR ex-
pression were accompanied by the reversal of DNA
methylation (Fig. 6).
Finally, we assessed the effects of the reversal of GR
expression in adult MS rats on the activation of NF-κB
signaling and neuroinflammatory responses to sevo-
flurane anesthesia. TSA pretreatment significantly sup-
pressed overactivated NF-κB signaling and excessive
neuroinflammation (Fig. 7). Moreover, TSA pretreatment
ameliorated sevoflurane anesthesia-induced cognitive
impairment in adult MS rats. These results suggested
that enhanced GR expression may suppress the inflam-
matory response and prevent cognitive impairment
induced by sevoflurane anesthesia. Taken together, our
findings support the conclusion that early life adversity
downregulates the expression of GR, enhances NF-κB sig-
naling, and worsens sevoflurane anesthesia-induced neuro-
inflammation, ultimately leading to cognitive impairment.
There are several limitations and caveats that should
be considered in this study. First, we did not systematic-
ally investigate the effects of MS on the function of the
hypothalamic–pituitary–adrenal (HPA) axis and instead
focused on the expression of GR in the hippocampus,
which is closely linked to HPA axis function [52]. It is
worth noting that higher cortisol levels and ineffective
dexamethasone treatments have been reported in POCD
patients [53, 54]. However, the current results suggested
that the MS-induced downregulation of GR expression
in the hippocampus may amplify neuroinflammation
and cause cognitive impairment, which will allow us to
further investigate the association between early life
Fig. 8 TSA attenuated sevoflurane-induced cognitive impairment in adult rats with neonatal maternal separation. a Schematic illustration of the
experimental timeline. MS maternal separation, Sev anesthesia with 3% sevoflurane for 2 h, TSA trichostatin A, MWM Morris water maze, CFC
context fear conditioning. b TSA group rats had a shorter escape latency than DMSO group rats on the third and fourth days after sevoflurane
anesthesia. There was a statistically significant interaction of time and group between the different groups (*P < 0.05). Analysis was performed by
repeated-measures two-way ANOVA. c The time in the target quadrant in the TSA group was more than that in the DMSO group by the MWM
probe test. d There was no significant difference in the number of crossings of the platform area between the two groups of rats. e TSA group
rats exhibited increased freezing to context relative to DMSO group rats. *P < 0.05, **P < 0.01 versus DMSO. Error bars represent the means ± SD
(n = 10). Statistical analyses were performed with Student’s two-sample t test
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adversity, the HPA axis, and POCD. Second, MS can
induce DNA hypermethylation in other genes (e.g.,
brain-derived neurotrophic factor) in addition to the GR
gene, and the demethylation function of TSA is not
specific to the GR gene [55, 56]. More research is
needed to determine whether other mechanisms of early
life adversity are involved in cognitive impairment after
anesthesia. However, given the inflammatory mecha-
nisms of POCD, the epigenetic regulation of GR is most
likely the chief reason for MS-induced cognitive impair-
ment after anesthesia. Finally, volatile anesthetics seem
to have a confounding effect on the brain. Some benefi-
cial effects have been reported for isoflurane on the out-
come of cerebral ischemia-reperfusion injury, traumatic
brain injury, and lipopolysaccharide-induced cerebral
damage [57–59]. Perhaps volatile anesthetics have a
neuroprotective effect on brain injury. However, volatile
anesthetics themselves may have adverse effects on the
brain. Recent studies show that volatile anesthetics can
cause neuroinflammation and impairment in a normal
physiological state [10, 11].
Conclusions
We found that early life adversity may be associated with
increased vulnerability to cognitive decline after anesthesia.
These findings suggest that the downregulation of GR by
MS enhanced NF-κB signaling and sevoflurane anesthesia-
induced neuroinflammation, which plays an important role
in cognitive impairment. In addition, the regulation of GR
expression in the hippocampus may be one strategy to
prevent anesthesia-induced cognitive impairment under
certain conditions. This study provides insight into the
mechanisms by which early life adversity produces a future
risk of POCD. In future studies, it will be important to
further determine whether early life adversity is an inde-
pendent risk factor for POCD in clinical practice, ultimately
leading to safer anesthesia and better postoperative progno-
ses for people who have experienced early life adversity.
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